A carregar...

Emergence of Ceftolozane-Tazobactam-Resistant Pseudomonas aeruginosa during Treatment Is Mediated by a Single AmpC Structural Mutation

Ceftolozane-tazobactam is a cephalosporin-β-lactamase inhibitor combination that exhibits potent in vitro activity against Pseudomonas aeruginosa, including strains that are resistant to other β-lactams. The emergence of ceftolozane-tazobactam resistance among clinical isolates of P. aeruginosa has...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Antimicrob Agents Chemother
Main Authors: MacVane, Shawn H., Pandey, Ruchi, Steed, Lisa L., Kreiswirth, Barry N., Chen, Liang
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2017
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5700322/
https://ncbi.nlm.nih.gov/pubmed/28947473
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01183-17
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!